Abionyx Pharma SA
F:609
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abionyx Pharma SA
F:609
|
FR |
|
Compagnie Financiere Richemont SA
SIX:CFR
|
CH |
|
N
|
Northern Textiles And Garments JSC
VN:TET
|
VN |
|
T
|
Troax Group AB (publ)
F:5TOA
|
SE |
|
CoStar Group Inc
NASDAQ:CSGP
|
US |
|
C
|
China Pacific Insurance Group Co Ltd
F:75CB
|
CN |
|
Swiss Military Consumer Goods Ltd
BSE:523558
|
IN |
|
T
|
TTET Union Corp
TWSE:1232
|
TW |
|
Virtu Financial Inc
NASDAQ:VIRT
|
US |
|
Pendragon PLC
LSE:PDG
|
UK |
|
Chung Hung Steel Corp
TWSE:2014
|
TW |
|
Banca Profilo SpA
MIL:PRO
|
IT |
|
Imagineer Co Ltd
TSE:4644
|
JP |
|
E
|
Express Inc
XBER:02Z
|
US |
|
F
|
Federal Realty Investment Trust
F:WX2
|
US |
|
A
|
Amcor PLC
XMUN:485
|
UK |
|
T
|
Technip Energies NV
OTC:THNPY
|
FR |
|
V
|
Vocera Communications Inc
F:V00
|
US |
|
M
|
Moderna Inc
F:0QF
|
US |
|
L
|
Liberty Global PLC
NASDAQ:LBTYB
|
UK |
|
W
|
Wins Co Ltd
KOSDAQ:136540
|
KR |
|
BenQ Materials Corp
TWSE:8215
|
TW |
|
F
|
F-Code Inc
TSE:9211
|
JP |
|
M
|
Mercury Systems Inc
F:MCY
|
US |
Bankruptcy Probability
Abionyx Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Abionyx Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Abionyx Pharma SA
PAR:ABNX
|
78.3m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
450.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
206.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
179.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Abionyx Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Abionyx Pharma SA has total debt of 3m EUR. This includes both short-term (0 EUR) and long-term (3m EUR) debt.
You can find a full breakdown on its Balance Sheet.
